Medicus Pharma Announces Co-Development And License Agreement With Pfizer For CD228-Targeting ADC PF-08046031, Paying $12M Upfront And $15M In One Year; Pfizer Eligible For Over $1B In Milestones Plus Royalties

Benzinga Newsdesk www.benzinga.com Neutral 93.1%

Neg 0% Neu 93.1% Pos 0%

https://www.sec.gov/Archives/edgar/data/1997296/000106299326004806/form8k.htm

Comments

No comments yet. Be the first!